ESR1 and breast cancer: Metabolomic analysis of breast cancer patients showed that estrogen receptor positive tumors contain elevated levels of short and medium chain fatty acids, as well as increased carnitine derivative levels, compared to estrogen receptor negative, suggesting an elevated fatty acid transportation rate [66].